[{"address1": "2836 Center Port Circle", "city": "Pompano Beach", "state": "FL", "zip": "33064", "country": "United States", "phone": "954 380 8342", "website": "https://www.biostemtechnologies.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jason V. Matuszewski", "title": "CEO, President, Director & Secretary", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael A. Fortunato CPA", "title": "Chief Financial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Vanvurst", "title": "COO & Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David M. Woynarowski", "title": "Chief Medical Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Larry  Jones", "title": "Chief Revenue Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Irmgard  Huber M.D.", "title": "International Medical Advisor & Interim Chief Medical Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn F. McCarrey", "age": 65, "title": "Chief Commercial Officer", "yearBorn": 1958, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 11.02, "open": 11.0, "dayLow": 10.74, "dayHigh": 11.0, "regularMarketPreviousClose": 11.02, "regularMarketOpen": 11.0, "regularMarketDayLow": 10.74, "regularMarketDayHigh": 11.0, "beta": 1.887, "forwardPE": 5.2884617, "volume": 9676, "regularMarketVolume": 9676, "averageVolume": 26150, "averageVolume10days": 39050, "averageDailyVolume10Day": 39050, "bid": 10.75, "ask": 10.99, "bidSize": 40000, "askSize": 40000, "marketCap": 179160304, "fiftyTwoWeekLow": 1.49, "fiftyTwoWeekHigh": 15.5, "priceToSalesTrailing12Months": 3.088251, "fiftyDayAverage": 10.06736, "twoHundredDayAverage": 8.38668, "currency": "USD", "enterpriseValue": 183292688, "profitMargins": 0.00275, "sharesOutstanding": 16287300, "impliedSharesOutstanding": 16701200, "bookValue": 0.407, "priceToBook": 27.027027, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": 159380, "trailingEps": -0.73, "forwardEps": 2.08, "enterpriseToRevenue": 3.159, "enterpriseToEbitda": 120.775, "52WeekChange": 4.527638, "SandP52WeekChange": 0.23814905, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "BSEM", "underlyingSymbol": "BSEM", "shortName": "BioStem Technologies, Inc.", "longName": "BioStem Technologies, Inc.", "firstTradeDateEpochUtc": 1426599000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6de9dd51-24e6-3683-960d-7a225a8770f4", "messageBoardId": "finmb_245319", "gmtOffSetMilliseconds": -14400000, "currentPrice": 11.0, "targetHighPrice": 24.25, "targetLowPrice": 24.25, "targetMeanPrice": 24.25, "targetMedianPrice": 24.25, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 643241, "totalCashPerShare": 0.039, "ebitda": 1517639, "totalDebt": 4352550, "quickRatio": 1.089, "currentRatio": 1.127, "totalRevenue": 58013516, "debtToEquity": 65.531, "revenuePerShare": 3.961, "returnOnAssets": 0.03312, "returnOnEquity": 0.15348, "freeCashflow": 247041, "operatingCashflow": -2276432, "revenueGrowth": 71.737, "grossMargins": 0.94165003, "ebitdaMargins": 0.02616, "operatingMargins": 0.109969996, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-04"}]